Detalles de la búsqueda
1.
Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts.
J Transl Med
; 21(1): 576, 2023 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37633930
2.
Radioresistance of KRAS/TP53-mutated lung cancer can be overcome by radiation dose escalation or EGFR tyrosine kinase inhibition in vivo.
Int J Cancer
; 147(2): 472-477, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31359406
3.
Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour models.
Radiother Oncol
; 183: 109546, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36813172
4.
Overcoming radioresistance with the hypoxia-activated prodrug CP-506: A pre-clinical study of local tumour control probability.
Radiother Oncol
; 186: 109738, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37315579
5.
Toxicity and Efficacy of Local Ablative, Image-guided Radiotherapy in Gallium-68 Prostate-specific Membrane Antigen Targeted Positron Emission Tomography-staged, Castration-sensitive Oligometastatic Prostate Cancer: The OLI-P Phase 2 Clinical Trial.
Eur Urol Oncol
; 5(1): 44-51, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34785189
6.
Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas.
Cancers (Basel)
; 13(8)2021 Apr 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33919702
7.
Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial.
Radiother Oncol
; 155: 285-292, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33227356
8.
Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC).
Cancers (Basel)
; 13(22)2021 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34830750
9.
Screening and Validation of Molecular Targeted Radiosensitizers.
Int J Radiat Oncol Biol Phys
; 111(5): e63-e74, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34343607
10.
The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo.
Clin Transl Radiat Oncol
; 2: 7-12, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29657993
11.
EGFR-amplification plus gene expression profiling predicts response to combined radiotherapy with EGFR-inhibition: A preclinical trial in 10 HNSCC-tumour-xenograft models.
Radiother Oncol
; 124(3): 496-503, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28807520
12.
In reply to the Letter to the Editor by Chen and Lui regarding "Radiotherapy enhances uptake and efficacy of 90Y-cetuximab: A preclinical trial" by A Dietrich et al.
Radiother Oncol
; 161: 261-262, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34119587
13.
Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma.
Oncotarget
; 6(33): 34494-509, 2015 Oct 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26460734
14.
Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation.
Int J Radiat Oncol Biol Phys
; 88(1): 159-66, 2014 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24331663
15.
BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts.
Radiat Oncol
; 9: 207, 2014 Sep 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25234922
16.
Radiolabeled anti-EGFR-antibody improves local tumor control after external beam radiotherapy and offers theragnostic potential.
Radiother Oncol
; 110(2): 362-9, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24440046
Resultados
1 -
16
de 16
1
Próxima >
>>